Members |
acceptabilityId |
8p23.1 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
8q partial monosomy syndrome |
Preferred (foundation metadata concept) |
8q partial monosomy syndrome (disorder) |
Preferred (foundation metadata concept) |
8q partial trisomy syndrome |
Preferred (foundation metadata concept) |
8q partial trisomy syndrome (disorder) |
Preferred (foundation metadata concept) |
8q12 microduplication syndrome |
Preferred (foundation metadata concept) |
8q12 microduplication syndrome (disorder) |
Preferred (foundation metadata concept) |
8q13 microdeletion syndrome |
Preferred (foundation metadata concept) |
8q13 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
8q21.11 microdeletion syndrome |
Preferred (foundation metadata concept) |
8q21.11 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
8q21.11 microdeletion syndrome encompasses heterozygous overlapping microdeletions on chromosome 8q21.11 resulting in intellectual disability, facial dysmorphism comprising a round face, ptosis, short philtrum, Cupid's bow and prominent low-set ears, nasal speech and mild finger and toe anomalies. |
Preferred (foundation metadata concept) |
8q22.1 microdeletion syndrome |
Preferred (foundation metadata concept) |
8q22.1 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
8q24.3 microdeletion syndrome |
Preferred (foundation metadata concept) |
8q24.3 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
8th floor |
Acceptable (foundation metadata concept) |
9 |
Preferred (foundation metadata concept) |
9 |
Preferred (foundation metadata concept) |
9 (qualifier value) |
Preferred (foundation metadata concept) |
9 French gauge |
Preferred (foundation metadata concept) |
9 French gauge (qualifier value) |
Preferred (foundation metadata concept) |
9 cis-hexadecenoic acid |
Acceptable (foundation metadata concept) |
9 cis-octadecenoic acid |
Preferred (foundation metadata concept) |
9 cis-octadecenoic acid (substance) |
Preferred (foundation metadata concept) |
9 cis-octadecenoic acid and oil of turpentine only product |
Preferred (foundation metadata concept) |
9 cis-octadecenoic acid only product |
Preferred (foundation metadata concept) |
9 cis-octadecenoic acid- and oil of turpentine-containing product |
Preferred (foundation metadata concept) |
9 cis-octadecenoic acid-containing product |
Preferred (foundation metadata concept) |
9 mm caliber bullet, device |
Acceptable (foundation metadata concept) |
9 mm caliber bullet, device (physical object) |
Preferred (foundation metadata concept) |
9 mm calibre bullet |
Preferred (foundation metadata concept) |
9 nm filaments |
Preferred (foundation metadata concept) |
9 nm filaments (cell structure) |
Preferred (foundation metadata concept) |
9 o'clock position |
Preferred (foundation metadata concept) |
9 o'clock position (qualifier value) |
Preferred (foundation metadata concept) |
9 o'clock position on mammogram |
Preferred (foundation metadata concept) |
9 o'clock position on mammogram (finding) |
Preferred (foundation metadata concept) |
9 times a day |
Acceptable (foundation metadata concept) |
9 trans-Octadecenoic acid |
Preferred (foundation metadata concept) |
9 trans-Octadecenoic acid (substance) |
Preferred (foundation metadata concept) |
9,12,15-octadecatrienoic acid |
Acceptable (foundation metadata concept) |
9,12-octadecadienoic acid |
Acceptable (foundation metadata concept) |
9-Hydroxyrisperidone measurement |
Preferred (foundation metadata concept) |
9-Hydroxyrisperidone measurement (procedure) |
Preferred (foundation metadata concept) |
9-hexadecenoic acid |
Acceptable (foundation metadata concept) |
9-hydroxyrisperidone |
Preferred (foundation metadata concept) |
9-hydroxyrisperidone |
Acceptable (foundation metadata concept) |
9-hydroxyrisperidone (substance) |
Preferred (foundation metadata concept) |
9-octadecenoic acid |
Acceptable (foundation metadata concept) |
9.2 |
Preferred (foundation metadata concept) |
9.2 (qualifier value) |
Preferred (foundation metadata concept) |
9.30 o'clock position |
Preferred (foundation metadata concept) |
9.30 o'clock position (qualifier value) |
Preferred (foundation metadata concept) |
9.5 |
Preferred (foundation metadata concept) |
9.5 (qualifier value) |
Preferred (foundation metadata concept) |
90 |
Preferred (foundation metadata concept) |
90 (qualifier value) |
Preferred (foundation metadata concept) |
90 degree projection |
Acceptable (foundation metadata concept) |
90 degrees |
Preferred (foundation metadata concept) |
90 degrees (qualifier value) |
Preferred (foundation metadata concept) |
90 minute blood glucose level |
Preferred (foundation metadata concept) |
90 minute blood glucose level |
Preferred (foundation metadata concept) |
90 minute blood glucose level |
Acceptable (foundation metadata concept) |
90 minute blood glucose level (procedure) |
Preferred (foundation metadata concept) |
90 minute blood glucose level (procedure) |
Preferred (foundation metadata concept) |
90 minute blood glucose measurement |
Preferred (foundation metadata concept) |
90 minute blood glucose measurement (procedure) |
Preferred (foundation metadata concept) |
90 minute plasma FSH level |
Preferred (foundation metadata concept) |
90 minute plasma FSH level |
Preferred (foundation metadata concept) |
90 minute plasma FSH level |
Acceptable (foundation metadata concept) |
90 minute plasma FSH level (procedure) |
Preferred (foundation metadata concept) |
90 minute plasma FSH level (procedure) |
Preferred (foundation metadata concept) |
90 minute plasma FSH measurement |
Preferred (foundation metadata concept) |
90 minute plasma GH level |
Preferred (foundation metadata concept) |
90 minute plasma GH level |
Acceptable (foundation metadata concept) |
90 minute plasma GH level |
Preferred (foundation metadata concept) |
90 minute plasma GH level (procedure) |
Preferred (foundation metadata concept) |
90 minute plasma GH level (procedure) |
Preferred (foundation metadata concept) |
90 minute plasma GH measurement |
Preferred (foundation metadata concept) |
90 minute plasma LH level |
Acceptable (foundation metadata concept) |
90 minute plasma LH level |
Preferred (foundation metadata concept) |
90 minute plasma LH level |
Preferred (foundation metadata concept) |
90 minute plasma LH level (procedure) |
Preferred (foundation metadata concept) |
90 minute plasma LH level (procedure) |
Preferred (foundation metadata concept) |
90 minute plasma LH measurement |
Preferred (foundation metadata concept) |
90 minute plasma TSH level |
Preferred (foundation metadata concept) |
90 minute plasma TSH level |
Acceptable (foundation metadata concept) |
90 minute plasma TSH level |
Preferred (foundation metadata concept) |
90 minute plasma TSH level (procedure) |
Preferred (foundation metadata concept) |
90 minute plasma TSH level (procedure) |
Preferred (foundation metadata concept) |
90 minute plasma TSH measurement |
Preferred (foundation metadata concept) |
90 minute plasma cortisol level |
Acceptable (foundation metadata concept) |
90 minute plasma cortisol level |
Preferred (foundation metadata concept) |
90 minute plasma cortisol level |
Preferred (foundation metadata concept) |
90 minute plasma cortisol level (procedure) |
Preferred (foundation metadata concept) |
90 minute plasma cortisol level (procedure) |
Preferred (foundation metadata concept) |
90 minute plasma cortisol measurement |
Preferred (foundation metadata concept) |
90 minute plasma cortisol measurement (procedure) |
Preferred (foundation metadata concept) |
90 minute plasma follicle stimulating hormone measurement |
Acceptable (foundation metadata concept) |
90 minute plasma follicle stimulating hormone measurement (procedure) |
Preferred (foundation metadata concept) |